Gilead Sciences
NASDAQ: GILD
$74.52
-$0.52 (-0.7%)
Closing price November 16, 2023
While many Wall Street firms are suggesting short Treasury paper and money markets now, for long-term investors looking for growth and income, healthcare is the place to be for the rest of 2023 and...
Published:
Monday's top analyst upgrades and downgrades included Adobe, Apple, Arch Capital, ChargePoint, CSX, Digital Ocean, First Solar, Gilead Sciences, Lucid, Shopify and Snowflake.
Published:
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange,...
Published:
When Nasdaq rebalances its Nasdaq 100 index, 7 top companies in the index will be upsized, and all are Buy rated across Wall Street.
Published:
The highest-yielding stocks in the Nasdaq offer a contrarian angle for the rest of 2023. They all have some solid defensive qualities, and they are offering among the best entry points seen in some...
Published:
Wednesday's top analyst upgrades and downgrades included Amgen, Canadian Pacific Kansas City, Carvana, Coinbase Global, Etsy, First Horizon, GE Healthcare Technologies, Gilead Sciences, Home Depot,...
Published:
Monday's top analyst upgrades and downgrades included CyberArk Software, Diageo, Dish Network, Electronic Arts, Fox, Gilead Sciences, Molson Coors Beverage, O’Reilly Automotive, PacWest Bancorp,...
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, Bluebird Bio, Carnival, Fortinet, General Motors, Gilead Sciences, Hasbro, Hershey, Intel, International Paper, Masco, Mobileye...
Published:
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
Published:
Last Updated:
Given that the Nasdaq has only twice had two down years in a row, the five highest-yielding stocks in the index offer a contrarian angle for 2023 for growth and income investors looking for a way...
Published:
Wednesday's top analyst upgrades and downgrades included Amazon, AMC Entertainment, Apollo Global Management, Apple, Block, Capital One Financial, Carlyle, CVS Health, Etsy, Fox, Gilead Sciences,...
Published:
Wednesday's top analyst upgrades and downgrades included Affirm, American Express, Block, Centene, Etsy, Gilead Sciences, KeyCorp, Norwegian Cruise Line, Okta, PayPal, Philip Morris International,...
Published:
Friday's top analyst upgrades and downgrades included ADT, Costco Wholesale, CrowdStrike, Gilead Sciences, Liberty Global, Otis Worldwide, PagSeguro Digital, Palo Alto Networks, Salesforce, Sunrun,...
Published:
Investors may be able to ride a potential Santa Claus rally for the balance of 2022. These five high-yielding Nasdaq stocks have some solid defensive qualities and are offering among the best entry...
Published: